GlobeNewswire 12/28/2020 Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Inj...
GlobeNewswire 12/21/2020 ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 Glomerulopathy...
GlobeNewswire 11/20/2020 Sian Capital Sends Letter to OPKO Health Regarding its Decision to Apparently Withhold Rayaldee From...
GlobeNewswire 11/16/2020 Arch Oncology Appoints Ronald Krasnow, Esq. as Chief Operating Officer
GlobeNewswire 11/9/2020 ChemoCentryx Reports Third Quarter 2020 Financial Results and Recent Highlights
GlobeNewswire 11/9/2020 Cara Therapeutics Reports Third Quarter 2020 Financial Results
GlobeNewswire 11/9/2020 Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
GlobeNewswire 11/6/2020 ChemoCentryx Announces Plenary Session at ACR Convergence 2020 to Highlight Findings of ADVOCATE Pha...
GlobeNewswire 11/5/2020 Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Development...
GlobeNewswire 11/3/2020 ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Auth...
GlobeNewswire 10/29/2020 Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health
GlobeNewswire 10/29/2020 Sian Capital Highlights Paths to Meaningful Value Creation at OPKO Health
GlobeNewswire 10/29/2020 OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results
GlobeNewswire 10/20/2020 Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis pat...
GlobeNewswire 9/17/2020 ChemoCentryx Announces FDA Acceptance of the Avacopan New Drug Application (NDA) for the Treatment o...
GlobeNewswire 8/10/2020 ChemoCentryx Reports Second Quarter 2020 Financial Results and Recent Highlights
GlobeNewswire 8/10/2020 Cara Therapeutics Reports Second Quarter 2020 Financial Results
GlobeNewswire 8/5/2020 Sarepta Therapeutics Announces Second Quarter 2020 Financial Results and Recent Corporate Developmen...
GlobeNewswire 7/9/2020 ChemoCentryx Submits New Drug Application to the U.S. FDA for Avacopan in ANCA-Associated Vasculitis
GlobeNewswire 6/3/2020 ChemoCentryx Phase III ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis Highlighted in Oral ...
GlobeNewswire 5/21/2020 Atreca Announces Appointment of Kristine M. Ball to its Board of Directors
GlobeNewswire 5/18/2020 ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmen...
GlobeNewswire 5/11/2020 ChemoCentryx Reports First Quarter 2020 Financial Results and Recent Highlights
GlobeNewswire 5/11/2020 Cara Therapeutics Reports First Quarter 2020 Financial Results
GlobeNewswire 5/6/2020 Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Development...